Latest Singapore News

Unity Metals has opened a non-renounceable share purchase plan targeting $1 million to fund gold and copper-gold exploration in Cambodia and Thailand. Eligible shareholders can buy shares at a 15.2% discount, with attaching options subject to a later shareholder vote.

Steadfast Group has disclosed a notice from Pentwater Capital Management concerning equity derivatives under Takeovers Panel guidance. The filing does not reveal the position’s size, direction, counterparties or economic exposure, leaving its significance unresolved.

Stakk Limited (ASX:SKK) delivered a sharp FY2026 revenue increase and moved to audited operating profitability, but its next test is considerably larger: integrating ParaScript while servicing new debt and converting contracted revenue into cash. The company is targeting A$55.2 million of pro forma revenue and A$18.5 million of EBITDA in FY2027.

Macro Metals turned a largely exploratory business into a revenue-generating mining services operator in FY26, with statutory revenue rising to A$1.72 million and approximately A$21.13 million of work awarded. The progress came with a material warning: the auditor said additional funding remains necessary to support the company as it grows.

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

GreenX Metals has put a conceptual copper-silver target at Tannenberg and a major Poland arbitration award at the centre of its next phase. The annual report also shows the cost of that strategy: a $12.34 million loss, a $4.42 million project impairment and continued reliance on equity funding.

Me Today reported a NZ$2.66 million FY26 profit, but the result was dominated by a NZ$4.12 million gain from losing control of King Honey. The remaining business grew revenue and improved its operating loss, yet continued to consume cash and will rely on October warrant funding.

Stakk says recurring contracts now support 100% of its approximately A$55.2 million FY2027 pro-forma revenue forecast, while fresh international wins are being built into the FY2028 growth story. The company will establish Singapore as its non-US commercial, service and technology hub from November 2026.

Australian Oil Co has appointed Tom Streitberg as Executive Chairman for three years, with the incoming chair committing $300,000 to the company. The deal also introduces a substantial equity-based remuneration package and potential dilution for shareholders.

Tuas Limited (ASX:TUA) delivered a sharp FY2026 earnings lift as Simba’s mobile and broadband subscriber base expanded, with statutory profit rising 277% to S$26.0 million. The result arrives with the M1 acquisition abandoned, S$364.5 million raised but not yet allocated, and an unresolved Singapore spectrum investigation.

Firebrick Pharma has received a $293,000 R&D Tax Incentive payment linked to $673,000 of eligible development spending on new Nasodine products. The non-dilutive cash arrives as the company broadens its product range and pursues approvals in additional markets.

Orthocell has recorded the first commercial sales of its Remplir nerve repair product in Thailand, opening a new market estimated at US$84 million. The launch gives the company another distributor-led growth channel, although near-term sales are expected to remain modest.